<DOC>
	<DOCNO>NCT00736866</DOCNO>
	<brief_summary>The purpose study evaluate efficacy acetylcysteine compare placebo contrast-induced nephropathy prevention , 48 96 hour procedure use contrast . Contrast-induced nephropathy define increase 25 % serum creatinine procedure .</brief_summary>
	<brief_title>The Acetylcysteine Contrast-Induced Nephropathy Trial</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>At least one follow criterion : Aged 70 yearsold Chronic renal failure ( define serum creatinine high 1.5mg/dL within last 3 month ) Diabetes mellitus Congestive heart failure ventricular disfunction ( left ventricular ejection fraction le 0.45 ) Shock intraaortic balloon pump use Urgency emergency procedure Pregnant woman , breastfeed age 45 yearsold efficacious contraceptive method . Patients dialysis Previous inclusion trial Patient refusal inform consent Pacientes com Infarto Agudo Miocárdio com supradesnivelamento segmento ST no quais não seja possível administrar protocolo de hidratação pré e pósprocedimento .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>acetylcysteine</keyword>
	<keyword>contrast-induced nephropathy</keyword>
	<keyword>angiography</keyword>
	<keyword>angioplasty without Stent</keyword>
</DOC>